13F Notebook
← Dashboard
Fund detail

HHLR Advisors / Hillhouse (Zhang Lei)

china, growth, hillhouse, active

Quarters 30
2022-12-31 $4.74B
Positions 67
Showing 7 of 7 rows (filtered from 74)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 ACM RESH INC $0 0 -670,755 -100.00% 0.22%
2 ADC THERAPEUTICS SA $0 0 -500,000 -100.00% 0.06%
3 FORMA THERAPEUTICS HLDGS INC $0 0 -1,100,000 -100.00% 0.58%
4 MP MATERIALS CORP $0 0 -200,000 -100.00% 0.14%
5 PRELUDE THERAPEUTICS INC $0 0 -583,333 -100.00% 0.10%
6 UXIN LTD $0 0 -1,915,634 -100.00% 0.03%
7 VANECK ETF TRUST $0 0 -20,000 -100.00% 0.11%